Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Clinical trial NCT04730583 · COMPLETED

Trial details

NCT number: NCT04730583
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Neurofibroma

Start date: 2021-06-02
Primary completion: 2024-04-19
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.